Singapore markets closed
Explore/

Most bought by activist hedge funds

Most bought by activist hedge funds

61.45k followers20 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stocks that were bought the most by activist hedge funds in the last quarter.

Curated by Yahoo Finance

Follow this list to discover and track the stocks that were bought the most by activist hedge funds in the last quarter.

Background

Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.

Find other winning investment ideas with the Yahoo Finance Screener.

How are these weighted?

The stocks in this watchlist are weighted equally.

Performance

WatchlistChange today1-month return1-year returnTotal return
Most bought by activist hedge funds+0.73%---
^GSPC+0.80%+4.21%+23.24%+5574.74%

20 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
GSThe Goldman Sachs Group, Inc.456.52+6.29+1.40%4:00 pm GMT-42.61M2.34M147.21B
SPGIS&P Global Inc.427.51+5.92+1.40%4:00 pm GMT-41.69M1.33M133.77B
ICEIntercontinental Exchange, Inc.133.9+0.66+0.50%4:00 pm GMT-42.94M2.31M76.80B
APOApollo Global Management, Inc.116.16-0.61-0.52%4:00 pm GMT-45.13M2.13M66.10B
KVUEKenvue Inc.19.3+0.31+1.63%4:00 pm GMT-426.81M20.21M36.96B
HPQHP Inc.36.5-1.86-4.85%4:00 pm GMT-429.62M8.09M35.72B
ITGartner, Inc.419.67+5.19+1.25%4:00 pm GMT-4741.92k390.45k32.58B
IFFInternational Flavors & Fragrances Inc.96.18+0.64+0.67%4:00 pm GMT-42.68M1.90M24.56B
TEVATeva Pharmaceutical Industries Limited16.93+0.03+0.18%4:00 pm GMT-47.21M9.86M19.18B
CPAYCorpay, Inc.267.67+1.24+0.47%4:00 pm GMT-4644.42k485.82k18.81B
AERAerCap Holdings N.V.92.71+0.85+0.93%4:00 pm GMT-41.28M1.60M18.39B
WCCWESCO International, Inc.179.49+0.63+0.35%4:00 pm GMT-4769.10k724.77k9.12B
KDKyndryl Holdings, Inc.26.61-0.03-0.11%4:00 pm GMT-41.63M1.77M6.13B
ALITAlight, Inc.7.75+0.24+3.20%4:00 pm GMT-46.25M5.62M4.45B
AAPAdvance Auto Parts, Inc.70.64+3.68+5.50%4:00 pm GMT-42.59M1.88M4.21B
CLVTClarivate Plc5.7+0.08+1.42%4:00 pm GMT-45.53M4.46M3.81B
SDRLSeadrill Limited51.87+1.13+2.23%4:00 pm GMT-4397.08k604.40k3.61B
DHTDHT Holdings, Inc.12.1-0.11-0.90%4:00 pm GMT-41.53M1.59M1.95B
UANCVR Partners, LP81.79+0.46+0.57%4:00 pm GMT-415.01k45.85k864.49M
  • Yahoo Finance Video

    Chart of the day: What is private credit?

    Private credit has piqued the interest of major banks such as Goldman Sachs (GS) and Wells Fargo (WFC), with these financial institutions raising approximately $50 billion in private credit investments, according to a Bloomberg report. Yahoo Finance's Julie Hyman breaks down the private credit trend. For more expert insight and the latest market action, click here to watch this full episode of Asking for a Trend. This post was written by Angel Smith

  • Business Wire

    New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)

    TEL AVIV, Israel & PARSIPPANY, N.J., June 01, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of seven studies from its long-acting injectable (LAI) schizophrenia research program. Presentations include data informing clinical strategies for switching patients to UZEDY, an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the treatment of schizophrenia

  • Business Wire

    Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

    TEL AVIV, Israel & PARSIPPANY, N.J., June 01, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new patient- and physician-reported interim results from the Phase 4 IMPACT-TD Registry study, reinforcing that TD has a wide-reaching, multidimensional impact on patients’ quality of life. These interim findings from the IMPACT-TD study were presented at the 2024 Psych Congress Elevate Annual Meeting, taking place from May 30 –